| URN | urn:agi-llid:1026 |
|---|---|
| Name | CDKN1A |
| Description | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
| Connectivity | 978 |
| Notes | This gene encodes a potent cyclin-dependent kinase inhibitor. The encoded protein binds to and inhibits the activity of cyclin-CDK2 or -CDK4 complexes, and thus functions as a regulator of cell cycle progression at G1. The expression of this gene is tightly controlled by the tumor suppressor protein p53, through which this protein mediates the p53-dependent cell cycle G1 phase arrest in response to a variety of stress stimuli. This protein can interact with proliferating cell nuclear antigen (PCNA), a DNA polymerase accessory factor, and plays a regulatory role in S phase DNA replication and DNA damage repair. This protein was reported to be specifically cleaved by CASP3-like caspases, which thus leads to a dramatic activation of CDK2, and may be instrumental in the execution of apoptosis following caspase activation. Two alternatively spliced variants, which encode an identical protein, have been reported. |
| Swiss-Prot Accession | P38936 |
|---|---|
| Q6FI05 | |
| Q59ED0 | |
| Q96LE1 | |
| P39689 | |
| Q564P6 | |
| Q4FK34 | |
| Q64315 | |
| Q2WFZ6 |
| Unigene ID | Hs.370771 |
|---|---|
| Mm.195663 | |
| Mm.477660 | |
| Rn.10089 | |
| Mm.473510 |
| KEGG ID | hsa:1026 |
|---|---|
| mmu:12575 | |
| rno:114851 |
| Swiss-Prot ID | CDN1A_HUMAN |
|---|---|
| CDN1A_MOUSE | |
| Q6FI05_HUMAN | |
| Q564P6_MOUSE | |
| Q64315_RAT |
| Cell Localization | Cytoplasm |
|---|
| GO ID | 0030332 |
|---|---|
| 0004861 | |
| 0046872 | |
| 0004860 | |
| 0008270 | |
| 0000082 | |
| 0000086 | |
| 0007050 | |
| 0031668 | |
| 0008629 | |
| 0043066 | |
| 0030308 | |
| 0008285 | |
| 0045736 | |
| 0042326 | |
| 0030890 | |
| 0048146 | |
| 0006974 | |
| 0009411 | |
| 0000307 | |
| 0005737 | |
| 0005829 | |
| 0005654 | |
| 0005634 | |
| 0016301 | |
| 0005515 | |
| 0007049 | |
| 0043068 | |
| 0051726 | |
| 0032403 | |
| 0031100 | |
| 0045768 | |
| 0046685 | |
| 0051412 | |
| 0042493 | |
| 0051384 | |
| 0055093 | |
| 0014070 | |
| 0010243 | |
| 0010033 | |
| 0009636 | |
| 0004672 | |
| 0043071 |
| Pathway | PPARG Targets |
|---|---|
| VDR Targets |
| IPI ID | IPI00009384 |
|---|---|
| IPI00387000 | |
| IPI00108058 | |
| IPI00211647 |
| Ariadne Ontology | CDKN |
|---|
| Mouse chromosome position | 17 15.23 cM |
|---|
| GO Molecular Function | protein binding |
|---|---|
| metal ion binding | |
| zinc ion binding | |
| protein complex binding | |
| cyclin binding | |
| kinase activity | |
| protein kinase inhibitor activity | |
| cyclin-dependent protein kinase inhibitor activity |
| Homologene ID | 333 |
|---|
| Hugo ID | 1784 |
|---|
| GO Cellular Component | cytoplasm |
|---|---|
| cyclin-dependent protein kinase holoenzyme complex | |
| cytosol | |
| nucleus | |
| nucleoplasm |
| MGI ID | 104556 |
|---|
| Human chromosome position | 6p21.2 |
|---|
| GO Biological Process | negative regulation of cell proliferation |
|---|---|
| negative regulation of cell growth | |
| negative regulation of cyclin-dependent protein kinase activity | |
| negative regulation of apoptosis | |
| positive regulation of anti-apoptosis | |
| negative regulation of phosphorylation | |
| positive regulation of B cell proliferation | |
| positive regulation of programmed cell death | |
| induction of apoptosis by intracellular signals | |
| positive regulation of fibroblast proliferation | |
| regulation of cell cycle | |
| cell cycle | |
| cellular response to extracellular stimulus | |
| cell cycle arrest | |
| G1-S transition of mitotic cell cycle | |
| G2-M transition of mitotic cell cycle | |
| organ regeneration | |
| response to UV | |
| response to drug | |
| response to organic substance | |
| response to toxin | |
| response to glucocorticoid stimulus | |
| response to corticosterone stimulus | |
| response to arsenic | |
| response to organic nitrogen | |
| response to organic cyclic substance | |
| response to hyperoxia | |
| response to DNA damage stimulus |
| Rat chromosome position | 20p12 |
|---|
| Group | CDKN |
|---|---|
| cytoplasm | |
| cyclin-dependent protein kinase holoenzyme complex | |
| cytosol | |
| nucleus | |
| nucleoplasm | |
| protein binding | |
| metal ion binding | |
| zinc ion binding | |
| protein complex binding | |
| cyclin binding | |
| kinase activity | |
| protein kinase inhibitor activity | |
| cyclin-dependent protein kinase inhibitor activity | |
| negative regulation of cell proliferation | |
| negative regulation of cell growth | |
| negative regulation of cyclin-dependent protein kinase activity | |
| negative regulation of apoptosis | |
| positive regulation of anti-apoptosis | |
| negative regulation of phosphorylation | |
| positive regulation of B cell proliferation | |
| positive regulation of programmed cell death | |
| induction of apoptosis by intracellular signals | |
| positive regulation of fibroblast proliferation | |
| regulation of cell cycle | |
| cell cycle | |
| cellular response to extracellular stimulus | |
| cell cycle arrest | |
| G1-S transition of mitotic cell cycle | |
| G2-M transition of mitotic cell cycle | |
| organ regeneration | |
| response to UV | |
| response to drug | |
| response to organic substance | |
| response to toxin | |
| response to glucocorticoid stimulus | |
| response to corticosterone stimulus | |
| response to arsenic | |
| response to organic nitrogen | |
| response to organic cyclic substance | |
| response to hyperoxia | |
| response to DNA damage stimulus |
| RGD ID | 69328 |
|---|
| LocusLink ID | 1026 |
|---|---|
| 12575 | |
| 114851 |
| Alias | P21 |
|---|---|
| CIP1 | |
| SDI1 | |
| WAF1 | |
| CAP20 | |
| CDKN1 | |
| MDA-6 | |
| p21CIP1 | |
| cyclin-dependent kinase inhibitor 1A | |
| p21Cip1/Waf1 | |
| OTTHUMP00000016298 | |
| DNA synthesis inhibitor | |
| CDK-interaction protein 1 | |
| wild-type p53-activated fragment 1 | |
| melanoma differentiation associated protein 6 | |
| CDKI | |
| mda6 | |
| p21WAF | |
| cyclin-dependent kinase inhibitor 1A (P21) | |
| p21<WAF1/CIP1> | |
| cyclin-dependent kinase inhibitor 1A (p21, Cip1) | |
| p21/Cip1/Waf1 | |
| p21/Waf-1 | |
| p21/Waf-1/Cip1 | |
| p21 Cip1/Waf1/Sic1 | |
| Cyclin-dependent kinase inhibitor I | |
| wild-type p53-activated fragment I | |
| CDK-interaction protein I | |
| CDK-interacting protein 1 | |
| CDK-interacting protein I | |
| SDI I | |
| CDKN I | |
| p21/Cip1/Waf I | |
| WAF I | |
| MDA VI | |
| p21/Waf I | |
| CipI/WafI | |
| cyclin-dependent kinase inhibitor P21 Cip1/Waf1 | |
| p21/Cip1/Waf1/SDI1 | |
| Cip1/Waf1 | |
| Waf-1/Cip1 | |
| Cdkn1a | |
| p21/Cip | |
| cyclin-dependent kinase inhibitor P21 | |
| CDN1_HUMAN | |
| melanoma differentiating associated protein 6 | |
| melanoma differentiating associated protein VI | |
| CDK-interactive protein I | |
| CDK-interactive protein 1 | |
| p21/Waf-1/Cip I | |
| melanoma differentiation associated protein VI | |
| p21/Cip I | |
| p21 WAF1/CIP1 | |
| p21/Cip1 | |
| WAF1/Clip1 | |
| p21(WAF/CLIP1) | |
| WAF/CLIP1 | |
| P(21) |
| Organism | Homo sapiens |
|---|---|
| Mus musculus | |
| Rattus norvegicus |
| OMIM ID | 116899 |
|---|